key: cord-0024242-wp520j7j
authors: Cao, Luchang; Wang, Xinmiao; Zhu, Guanghui; Li, Shixin; Wang, Heping; Wu, Jingyuan; Lu, Taicheng; Li, Jie
title: Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review
date: 2021-11-26
journal: Integr Cancer Ther
DOI: 10.1177/15347354211061720
sha: 193224ed7ed12ef8455d76896f3e2e137bf6cbbe
doc_id: 24242
cord_uid: wp520j7j

Esophageal cancer (EC) is the sixth leading cause of cancer-related deaths worldwide. Western medicine has played a leading role in its treatment, but its prognosis remains unsatisfactory. Therefore, the development of effective therapies is important. Traditional Chinese medicine (TCM) has been practiced for thousands of years, and involves taking measures before diseases occur, deteriorate, and recur. Interestingly, there is growing evidence that TCM can improve the therapeutic effects in reversing precancerous lesions, inhibiting the recurrence and metastasis of EC. In this article, we review traditional Chinese herbs and formulas that have preventive and therapeutic effects on EC, summarize the application and research status of TCM in patients with EC, and discuss its shortcomings and prospects in the context of translational, evidence-based, and precision medicine.

There are an estimated 604 000 new esophageal cancer (EC) cases and 544 000 deaths each year, and the incidence and mortality rates of EC are ranked seventh and sixth in the world, respectively. 1 EC is mainly classified as esophageal squamous cell carcinoma (ESCC) or esophageal adenocarcinoma (EAC), of which ESCC accounts for about 90% with a 5-year survival rate of 10%, 2 and 30% to 40% of cases have local or distant metastasis once found. 3, 4 Smoking, excessive alcohol consumption, red meat, salted meat, fried food, Barrett's esophagus, gastroesophageal reflux disease, and obesity can increase the risk of EC. 5, 6 At present, EC is mainly treated by surgical resection, radiotherapy, chemotherapy, molecular targeted therapy, and immunotherapy, but the prognosis is still poor. [7] [8] [9] Traditional Chinese medicine (TCM) originated in ancient China. It has experienced different stages of prosperity, decline, and revival ( Figure 1 ) during over 5000s of years of medical practice. The main guiding concept of "seeking the root of the disease (Zhibing Qiuben)" is from a classic ancient book named "Huang Di Nei Jing." Under the overall and individualized concept, 10, 11 TCM teaches that qi, xue, yin, and yang are the basic materials to maintain human life activities, and the occurrence of diseases is due to their imbalance. The body is like a "soil environment," and cancer cells are like "seeds." TCM not only can directly eliminate carcinogenic "seeds," 12 but also improve the "soil environment" to make the body no longer suitable for "seed" growth. [13] [14] [15] [16] Maintaining esophageal patency (tongjiang in TCM) is beneficial in the therapeutic method. The key pathological factors of EC are deficiency (xu), stasis (yu), heat (re), and poison (du). Therefore, therapies such as replenishing qi, promoting blood circulation, invigorating the spleen and kidney, regulating qi and phlegm, and clearing heat and toxic substances are needed. Compared with Western medicine, TCM plays a supplementary and alternative role in EC, which has gained a satisfactory effect and attracted widespread attention. [17] [18] [19] [20] [21] In this article, we review the application status and mechanistic research of TCM and discuss its shortcomings and prospects in the context of integrated medicine, precision medicine, and evidencebased medicine. [22] [23] [24] [25] [26] Ancient Classical Formulas for the Treatment of EC Although EC itself was not described in ancient China, TCM was applied to improve clinical symptoms such as dysphagia. 27,28 Meanwhile, ancient Chinese herbal formulas gradually developed from single herbs to multiple drugs (formulas). Some ancient classical formulas have preventive and therapeutic effects on EC. For example, Liu-Jun-Zi-Tang 29 and Sha-Shen-Mai-Dong-Tang, 30 which supplement qi and nourish yin, can inhibit the growth of EC cells. Xiao-Chai-Hu-Tang 31 and Qi-Zhu-Yu-Ling-Tang 32 soothe the liver and regulate qi. They can prevent EC cell proliferation and improve clinical symptoms. Bu-Qi-Yun-Pi-Tang 30 and Liu-Wei-Di-Huang-Wan 33 are classical prescriptions for invigorating the spleen and tonifying the kidney. They can prevent the progression of EC. Formulas such as Qi-Ge-San 34 and Tong-You-Tang 30 remove phlegm, dampness, blood stasis, and poisonous substances, which can strengthen the body to resist disease (Table 1) .

EC mostly develops from esophageal squamous epithelial dysplasia, 47 and chronic inflammatory and mucosal hyperplasia are important factors for the gradual development of the esophageal epithelium into dysplasia. 48, 49 Clinical studies have shown that TCM has promise in preventing EC. For example, a randomized controlled trial showed that Fu-Fang-Cang-Dou-Wan (Atractylodes Rhizome, Radix Sophorae Tonkinensis, and green tea) can reduce the 2-year cancer rate, cellular DNA content, and proliferation index of patients with severe hyperplasia of esophageal epithelial cells. 50 Randomized controlled trials showed that Kang-Ai-Yi-Pian (Dioscorea Bulbifera L, Polygonum Bistorta L, In 2003, TCM achieved good results in the fight against atypical pneumonia, which made it come to the fore. In 2015, the Nobel Prize of artemisinin research promoted TCM internationalization process. During COVID-19 in 2019, TCM's advantages became even more apparent in improving symptoms and reducing mortality, which has received extensive international attention and recognition. 

Surgery and chemoradiotherapy, as the main treatments for EC, have toxic side effects and affect the daily quality of life of patients. [56] [57] [58] [59] It is reported that TCM combined with Western medicine can improve the efficacy of such treatments and prolong survival. 60 For instance, 3 randomized controlled trials have shown that Bu-Yi-San-Jie-Yin can improve postoperative symptoms of fatigue, slurred speech, shortness of breath, fatigue, and spontaneous sweating and the levels of immune and nutritional indicators (P < 0.05) after EC radical resection. 61 Xiao-Ai-Ping combined with S-1 and cisplatin could improve the response rate and disease control rate, prolong progressionfree-survival (PFS) and overall survival (OS) of patients with advanced EC compared with chemotherapy alone. 62 Concurrent chemoradiotherapy combined with Qing-Fei-Qu-Yu-Tang in patients with advanced EC could reduce the incidence of radiation pneumonitis and radiation lung damage and improve the survival and quality of life of patients (P < .05) . 63 A retrospective clinical study determined that chemoradiotherapy and β-elemene can improve the OS, PFS, and 3-year survival of patients with ESCC, which provides a basis for the clinical application of βelemene herbs, such as Zedoary. 64 

In patients with EC, ginseng and Astragalus Membranaceus are often used to improve appetite and fatigue. Pinellia ternata and Ruddle Ocher can improve nausea. Concha Arcae and cuttlebone are applied to improve acid heartburn and rhubarb and Areca Catechu are used to improve constipation. 65 

Aberrant cell proliferation is a hallmark of cancer. 73 Studies have shown that lupeol acetate and baohuoside-I, the active ingredients of Cortex Periplocae Radicis, can inhibit the proliferation of EC cells by downregulating the expression of β-catenin and its downstream proteins. 74,75 β-elemene (an active ingredient of Curcumae Longae Rhizoma) can inhibit the proliferation of ESCC by regulating hTERT expression mediated by long non-coding RNA. 76 In addition, Chinese herbal medicines and their active ingredients, such as Momordicae Semen (Mubiezi), curcumin (an active ingredient of Curcumae Longae Rhizoma) and Jia-Wei-Tong-You-Tang (Persicae Semen, Carthami Flos, Cimicifugae Rhizoma, Arecae Semen, Scutellariae Barbatae Herba, and Hedyotis Diffusae Herba) can also inhibit cell proliferation to exert anti-EC effects. [77] [78] [79] The mechanism of action of TCM against EC is detailed in Figure 2 .

Senescence is an irreversible state of cell cycle arrest. Accumulating evidence suggests that the induction of cellular senescence is an effective method in cancer therapy. 80, 81 Interestingly, studies have shown that gypenoside L (a saponin isolated from Gynostemma pentaphyllum) could promote aging-related cytokines (such as IL-1α, IL-6, TIMP-1, CXCL-1, and CXCL-2) and aging-related cyclins (p21 and p27) by increasing the activity of SA-βgalactosidase, resulting in cells arrested in the S phase. Coincidentally, pathways regulating cellular senescence have an impact on the development of ESCC. Among them, p38 MAPK activation may be a key link during malignant carcinogenesis and transformation of ESCC 82 ; the MAPK/ ERK pathway can inhibit the proliferation and invasion of ESCC cells by targeting MAP3K9. 83 NF-κB signaling is overactivated in ESCC cells, and its inhibition leads to decreased cell growth and cell proliferation. 84 Another study showed that gypenoside L can induce senescence in EC cells by activating the p38, ERK, MAPK, and NF-κB pathways. 85 

Autophagy is a mechanism by which cellular materials are degraded by lysosomes. It has opposing and context-dependent roles in cancer, and is proposed as a therapeutic approach for tumors. 86 Ursolic acid can inhibit the growth and metastasis of EC cells by reactive oxygen species (ROS)-mediated autophagy. 87 Echinatin (an active ingredient of licorice), dihydroartemisinin (an active ingredient of Artemisinin), and ginsenoside Rk3 (an active ingredient of ginseng and Notoginseng Ginseng) can induce autophagy and exert anti-EC effects by inhibiting the Akt/mTOR signaling pathway. [88] [89] [90] Moreover, apoptosis, a biological process in which multiple factors induce programed cell death, has also been shown to be a promising effective way to prevent cancer growth and progression. 91 Studies have shown that TCM can induce apoptosis to inhibit EC progression. For example, Jaridonin, the active ingredient of Isodon rubescens, has been reported to induce apoptosis by inducing ROS generation, releasing cytochrome c, and activating caspases. 92 Picropodophyllotoxin, the main component of Podophyllum Hexandrum Root, has an apoptotic effect on ESCC cells by increasing ROS levels and inducing the JNK/p38 signaling pathway. 93 The PI3K/AKT/mTOR signaling pathway is key in the oncogenic process of ESCC and has potential value for prognostic markers and treatment of ESCC. 94 Matrine (an active ingredient of Sophora flavescens), casticin (the main active ingredient of Vitex spp.), oridonin (an active ingredient of Rabdosia Rubescens), and ginsenoside Rg5 (a major active ingredient of red ginseng) can induce apoptosis through the BID-mediated mitochondrial pathway, 95 the JNK signaling pathway, 96 the PI3K/ AKT/mTOR and Ras/Raf pathways, 97 and the PI3K/PKB signaling pathway, 98 respectively.

Metastasis is the real cause of malignant tumor characteristics 99 and causes 90% of cancer-related deaths. 100 Studies have shown that berberine (an active ingredient of Coptidis Rhizoma) can inhibit EC cell migration by downregulating the expression of CCR7 and CXCR4. 101 Curcumin (an active ingredient of Curcumae Longae Rhizoma), can inhibit the formation of the lipid raft-associated Rac1/PI3K/ Akt signaling complex to improve Sdf-1α induced EC cell invasion. 102 In addition, epithelial-to-mesenchymal transition (EMT) is a key factor in the regulation of tumor cell metastasis. 103 Interestingly, Qi-Ge-San and Cinobufotalin injection can inhibit EMT by inhibiting the expression of Gas6/axl and the activation of the Snail/Twist pathway, respectively. 104, 105 Angiogenesis is a necessary condition for tumor growth and metastasis. Inhibiting angiogenesis and tumor vascular supply can contribute to the control of tumor cell growth and metastasis. 106 Scholars have speculated that the overexpression of PDGFR-α is associated with tumor-related angiogenesis and progression. 107 The PDGFR-α expression rates of EAC and ESCC are 91% and 100%, respectively. VEGF expression is closely related to angiogenesis, disease progression, and prognosis in ESCC. 108, 109 Studies have shown that Qi-Ge-San 110 and Liu-Jun-Zi-Tang 111 can reduce cellular angiogenesis. Among them, Qi-Ge-San may exert anti-EC effects by downregulating EGFR, PDGFR, VEGF, and PLC-γ1 expression. 112

Drug resistance is a common phenomenon during cancer chemotherapy and is one of the causes of poor prognosis. The development of multidrug resistance in tumor cells is closely related to the expression of P-gp and MRP. 113, 114 In addition, TCM and its active ingredients, such as Cinobufotalin Injection and curcumin, can improve drug resistance and enhance the sensitivity of EC cells to chemotherapeutic drugs by inhibiting the expression of P-gp and MRP. 105, 115 Luteolin may also reverse multidrug resistance by inhibiting the FAK/Src/PI3K/Akt signaling pathway in ESCC cells. 116 Studies have shown that downregulation of microRNA-138 expression is associated with cell resistance. 117, 118 Survivin is a target gene of microRNA-138, and EC cancer cells with elevated survivin protein expression are drug-resistant. α-Solanine (an active ingredient of Solanum Nigrum Linn) can promote the chemosensitivity of EC cells to 5-fluorouracil/cisplatin by upregulating microRNA-138 expression and downregulating survivin expression. 119 

Immune escape, triggered by T cell reduction or dysfunction, is one of the mechanisms by which cancer cells avoid the immune system. 120 Studies have shown that Compound Radix Sophorae Flavescentis Injection 121 (Radix Sophorae Flavescentis, Radix Polygoni Multiflori, Trogopterus Dung) can improve the levels of CD3 + , CD4 + , and CD4 + /CD8 + T cells and strengthen cellular immune function in elderly EC patients undergoing chemoradiotherapy. Zhenqi Fuzheng Granules 122 can increase the levels of CD3 + , CD4 + , and CD8 + T cells and enhance the immune capacity of EC patients. In addition, mature dendritic cells (DCs), as antigen-presenting cells in the immune system, have an ultra-strong ability to acquire antigens and present them to T cells. 123 Qi-Ge-San can reduce the EC inhibitory effect on DCs by inhibiting the STAT3 signaling pathway. 124 At the same time, Treg cells are also involved in the development of tumors by inhibiting tumor immunity. 125 A study has shown that Lian-Hua-Shen-Jia-Fang (Forsythiae Fructus, Trichosanthis Radix, Codonopsis Radix, and Cortex Periplocae) can slow down the process of precancerous esophageal lesions by inhibiting the expression of Treg cells. 126

The prognosis of patients with advanced EC remains unsatisfactory. The 5-year survival rate is approximately 5%. 127 With more EC-relevant clinical trials being carried out in recent years, targeted and non-targeted immunotherapies have been gradually developed. It is expected that these therapies combined with surgery, radiotherapy, and chemotherapy, will be the future of multimodal treatment for EC. 128, 129 However, drug resistance in targeted immunotherapy is an unavoidable and complicated problem. TCM plays an important role in immune and targeted therapies, such as synergism and attenuation, improvement of drug sensitivity, and even reversal of drug resistance. For example, studies have demonstrated that TCM has unique advantages in reversing the acquired drug resistance of EGFR tyrosine kinase inhibitors in lung cancer. 130 Accordingly, whether TCM plays a positive role in reversing targeted and immunotherapy drug resistance in EC treatment remains a valuable problem to be solved. Moreover, it is worth exploring the mechanisms of TCM in the EC microenvironment and its effect on oral and intestinal flora.

TCM has shown great potential for the treatment of EC. It is well-suited to the complex mechanism of EC because of its natural complexity. However, there is also a wider dilemma: due to the multiple targets and pathways of TCM, the anti-EC mechanisms of most Chinese herbs have not been fully elucidated. It is necessary to explore regulatory networks associated with TCM mechanisms with the help of multidisciplinary, large-sample, and multi-omics techniques. Meanwhile, TCM is at a disadvantage in setting clinical pathways and guidelines for EC due to the lack of high-quality evidence-based studies, which greatly limits the application and development of TCM. In the future, high-quality randomized clinical trials with larger sample sizes across multiple centers need to be performed to improve this.

LC and XW conceived the work. LC, XW, and GZ wrote and drafted the manuscript. LC, XW, GZ, and JL discussed and edited the manuscript. SL, HW, JW, and TL assisted in revising the second edition. JL funded the study. All authors read and approved the final version of the manuscript.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Major projects funded by Beijing Science and Technology Plan: (No.D161100005116004). 

Jie

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Identification of genomic alterations in oesophageal squamous cell cancer

Esophageal carcinoma

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Esophageal cancer: risk factors, genetic association, and treatment

Increased risk of esophageal squamous cell carcinoma associated with frequent and long-term consumption of salted meat and salted fat

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: a phase II study

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Weight loss, satiety, and the postprandial gut hormone response after Esophagectomy: a prospective study

Integration of traditional Chinese medicine and Western medicine in the era of precision medicine

The role of Chinese medicine in health maintenance and disease prevention: application of constitution theory

Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology

Anti-metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial-mesenchymal transition and angiogenesis

Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway

Qigesan inhibits migration and invasion of esophageal cancer cells via inducing connexin expression and enhancing gap junction function

COVID-19 pandemic: epidemiology, etiology, conventional and non-conventional

Effect of Xiaochaihu decoction on the proliferation and apoptosis of human Esophageal cancer cell line Eca-109

Experience of Qizhu Yuling decoction in treating esophageal cancer

Institute of Chinese Medicine Guang'anmen Hospital. Curative effect of Liuwei Dihuang pill on 30 cases of esophageal epithelial cell hyperplasia

Synergistic inhibition effect of qige powder and cisplatin on esophageal EC9706 cell growth mediated by miR-21

Prescriptions of the Bureau of Taiping People's Welfare. People's Medical Publishing House

Secret Recipes of Treating Wounds and Bone-Setting Taught by Celestials. People's Medical Publishing House

Treatise on Cold-Attack. People's Medical Publishing House

Theory of Spleen and Stomach. People's Medical Publishing House

Febrile Disease Differentiation. People's Medical Publishing House

Medicine Comprehended. People's Medical Publishing House

Medical Forest Correction. People's Medical Publishing House

Key to the Therapeutics of Children's Diseases. People's Medical Publishing House

The Theory of Internal and External Injury Differentiation. People's Medical Publishing House

Elbow Backup Emergency. China Traditional Chinese Medicine Publishing House

Integrating Chinese and Western Medicine

Three-Cause-One-Disease-Syndrome Theory. People's Medical Publishing House

Squamous dysplasiathe precursor lesion for esophageal squamous cell carcinoma

Analysis of basement membrane structure and inflammation during the development of esophageal squamous cell carcinoma in the Chinese Chaoshan high risk region

Hot beverage and food intake and esophageal cancer in southern China

Clinical study of compound Cangdou pills on precancerous lesions of esophageal cancer

Blocking treatment of precancerous lesions of esophagus with anti-cancer B tablets

Clinical analysis of 60 cases of esophageal mucosal atypical hyperplasia treated with Xinkaikujiang method

29 cases of esophageal epithelial atypical hyperplasia treated by Qingre Huoxue mixture

Clinical observation on 52 cases of esophageal epithelial hyperplasia treated with modified Liuwei Dihuang decoction

Effect of modified qigesan on the recurrence and metastasis rate and quality of life among patients after radical resection of Esophageal carcinoma

Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan

Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer

Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection

Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse model

Effect of Buyi Sanjie decoction adjuvant enteral nutrition support on quality of life and immune function in patients with radical resection of esophageal cancer after surgery

Betaelemene treatment is associated with improved outcomes of patients with esophageal squamous cell carcinoma

Huang Jin-chang's experience in the treatment of esophageal cancer

Clinical study on prevention and treatment for acute radiation esophagitis by modified Lophatheri and Gypsi fibrosi decoction

Palliation of malignant dysphagia in esophageal cancer: a literature-based review

A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain

Complementary and alternative medicine for cancer pain: an overview of systematic reviews

Efficacy of compound Kushen injection in relieving cancer-related pain: a systematic review and meta-analysis

Clinical research on nourishing yin and unblocking meridians recipe combined with opioid analgesics in cancer pain management

Mathematical models of tumor cell proliferation: a review of the literature

Inhibitory effects of lupeal acetate of Cortex periplocae on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis

The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophageal carcinoma via β-catenin-dependent signaling

β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression

Effect of modified Tongyou decoction on esophageal cancer cell vasculogenic mimicry and proliferationunder hypoxia conditions

Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats

A potential anti-tumor herb bred in a tropical fruit: insight into the chemical components and pharmacological effects of Momordicae semen

Cellular senescence checkpoint function determines differential notch1 -dependent oncogenic and tumor-suppressor activities

Cellular senescence: aging, cancer, and injury

The status of phosphorylated p38 in esophageal squamous cell carcinoma

MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9

NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation

Gypenoside L inhibits proliferation of Liver and esophageal cancer cells by inducing senescence

Targeting autophagy in cancer

Reactive oxygen species-mediated autophagy by Ursolic acid inhibits growth and metastasis of Esophageal cancer cells

Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy

Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis

The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/akt/mTOR pathway

Traditional Chinese medicine targeting apoptotic mechanisms for esophageal cancer therapy

Jaridonin, a novel ent-kaurene diterpenoid from Isodon rubescens, inducing apoptosis via production of reactive oxygen species in esophageal cancer cells

Picropodophyllotoxin, an epimer of podophyllotoxin, causes apoptosis of human esophageal squamous cell carcinoma cells through ROS-mediated JNK/P38 MAPK pathways

Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway

Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells

Casticin inhibits esophageal cancer cell proliferation and promotes apoptosis by regulating mitochondrial apoptotic and JNK signaling pathways

Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and ras/raf pathways

Ginsenoside rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide-3 kinase/protein kinase B signaling pathway

Biologie de la métastase

Cancer metastasis -tricks of the trade

Role of Berberine on molecular markers involved in migration of esophageal cancer cells

Suppressing the formation of lipid raft-associated Rac1/ PI3K/akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells

EMT: present and future in clinical oncology

Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/ axl-induced epithelial-mesenchymal transition

Effect of cinobufacini on chemotherapy sensitivity and toxicity of human esophageal carcinoma cells in vitro

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

PDGFR-α and CD117 expression pattern in Esophageal carcinomas

Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression

Vascular endothelial growth factor in esophageal cancer

Effect of Liujunzi decoction on angiogenesis of esophageal cancer cell line EC9706

Inhibitory effect of Qigesan and its separated formula on angiogenesis of esophageal carcinoma Eca109 cell-transplanted nude mouse tumor

Natural products as alternative choices for P-glycoprotein (P-gp) inhibition

Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases

Curcumin reverses multidrug resistance of human esophageal cancer Eca-109 / VCR cells. Master's thesis

The role of luteolin in the multidrug resistance of esophageal squamous cell carcinoma and its molecular mechanism. Master's thesis

miR-138 might reverse multidrug resistance of leukemia cells

Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP)

α-solanine enhances the chemosensitivity of esophageal cancer cells to 5-FU/DDP by inducing microRNA-138 expression. Master's thesis

T cell exhaustion in cancer: mechanisms and clinical implications

Effect of compound Radix Sophorae flavescentis injection combined with chemoradiotherapy on serum CEA, CA199 and CA125 levels and cellular immune function in elderly patients with esophageal cancer

Zhenqi fuzheng granules on influence of life quality and immune function in patients with esophageal cancer chemotherapy

Dendritic cell-based immunotherapy

The effect of qige powder on the mature dendritic cells inhibited by the esophageal cancer EC9706 cells

Regulatory T (treg) cells in cancer: Can Treg cells be a new therapeutic target?

Immunomodulatory effect of the active ingredients of traditional Chinese medicine based on the Compatibility Mechanism on early esophageal dysplasia

Cancer stat facts: esophageal cancer

Immunotherapy for esophageal cancers: what is practice changing in 2021?

Advances in targeted therapy for esophageal cancer

Study on mechanism of Fuzheng Jiedu formula ameliorating EGFR -TKIs acquired resistance by lung cancer stem cells